MP22-18 AGE INFLUENCE ON ADVERSE EVENTS IN PATIENTS TREATED WITH ABIRATERONE PLUS PREDNISONE, ENZALUTAMIDE AND RADIUM223 FOR METASTATIC CASTRATION RESISTANT PROSTATE CANCER: ANALYSIS OF REAL LIFE DATA FROM EUDRA VIGILANCE DATABASE.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.